Skip to content

U.S. backs WTO extension of deadline on patent waivers for COVID-19 tests and treatments

WTO has long deadlocked over a proposed annual waiver of parts of the 1995 TRIPS Agreement, a major intellectual property agreement, that would allow any nation or company to make a vaccine if it has the recipe and ingredients.

The U.S. announced support for extending a key WTO deadline on COVID-19 diagnostics and therapeutics.
The U.S. announced support for extending a key WTO deadline on COVID-19 diagnostics and therapeutics. (AN/Mufid Majnun / Unsplash)

This article is for subscribers only

Get started for free

No credit card required. Already have an account? Log in

Latest